Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Yaffe

Showing results (181-190 of 267) with videos related to

Pageof 27
Sort By:
Nature Communications|May 20, 2018
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticlesFred C Lam, Stephen W Morton, Jeffrey Wyckoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Dual recognition of phosphoserine and phosphotyrosine in histone variant H2A.X by DNA damage response protein MCPH1Namit Singh, Harihar Basnet, Timothy D Wiltshire, et al.
The Journal of Biological Chemistry|December 10, 2009
Identification of a suppressive mechanism for Hedgehog signaling through a novel interaction of Gli with 14-3-3Yoshinari Asaoka, Fumihiko Kanai, Tohru Ichimura, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2020
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trialHunter B Moore, Christopher D Barrett, Ernest E Moore, et al.
Cancer Cell|November 26, 2015
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Cancer Cell|August 28, 2017
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Injury|March 16, 2020
Circulating Factors in Trauma Plasma Activate Specific Human Immune Cell SubsetsLaura A Cahill, Fei Guo, Jennifer Nguyen, et al.
Science (New York, N.Y.)|August 16, 2005
TAZ, a transcriptional modulator of mesenchymal stem cell differentiationJeong-Ho Hong, Eun Sook Hwang, Michael T McManus, et al.
The Journal of Trauma and Acute Care Surgery|May 23, 2018
A subset of five human mitochondrial formyl peptides mimics bacterial peptides and functionally deactivates human neutrophilsElzbieta Kaczmarek, Carl J Hauser, Woon Yong Kwon, et al.
Arthritis and Rheumatism|August 1, 2009
Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell functionLars Stangenberg, Chris Ellson, Virna Cortez-Retamozo, et al.
Pageof 27

Showing results (181-190 of 267) with videos related to

Sort By:
Pageof 27
Nature Communications|May 20, 2018
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticlesFred C Lam, Stephen W Morton, Jeffrey Wyckoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Dual recognition of phosphoserine and phosphotyrosine in histone variant H2A.X by DNA damage response protein MCPH1Namit Singh, Harihar Basnet, Timothy D Wiltshire, et al.
The Journal of Biological Chemistry|December 10, 2009
Identification of a suppressive mechanism for Hedgehog signaling through a novel interaction of Gli with 14-3-3Yoshinari Asaoka, Fumihiko Kanai, Tohru Ichimura, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2020
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trialHunter B Moore, Christopher D Barrett, Ernest E Moore, et al.
Cancer Cell|November 26, 2015
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Cancer Cell|August 28, 2017
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Injury|March 16, 2020
Circulating Factors in Trauma Plasma Activate Specific Human Immune Cell SubsetsLaura A Cahill, Fei Guo, Jennifer Nguyen, et al.
Science (New York, N.Y.)|August 16, 2005
TAZ, a transcriptional modulator of mesenchymal stem cell differentiationJeong-Ho Hong, Eun Sook Hwang, Michael T McManus, et al.
The Journal of Trauma and Acute Care Surgery|May 23, 2018
A subset of five human mitochondrial formyl peptides mimics bacterial peptides and functionally deactivates human neutrophilsElzbieta Kaczmarek, Carl J Hauser, Woon Yong Kwon, et al.
Arthritis and Rheumatism|August 1, 2009
Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell functionLars Stangenberg, Chris Ellson, Virna Cortez-Retamozo, et al.
Pageof 27